These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 16641884)
1. Pharmacogenetics of antipsychotic-induced weight gain. Fraguas D; Kirchoff D Med Sci Monit; 2006 May; 12(5):LE6-7. PubMed ID: 16641884 [No Abstract] [Full Text] [Related]
2. Pilot study of the G-protein beta3 subunit gene (C825T) polymorphism and clinical response to olanzapine or olanzapine-related weight gain in persons with schizophrenia. Bishop JR; Ellingrod VL; Moline J; Miller D Med Sci Monit; 2006 Feb; 12(2):BR47-50. PubMed ID: 16449941 [TBL] [Abstract][Full Text] [Related]
3. Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis. Souza RP; De Luca V; Muscettola G; Rosa DV; de Bartolomeis A; Romano Silva M; Kennedy JL Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1848-53. PubMed ID: 18793692 [TBL] [Abstract][Full Text] [Related]
4. Weight gain, antipsychotic drug treatment and pharmacogenomics. Reynolds GP Pharmacogenomics; 2002 Sep; 3(5):567-70. PubMed ID: 12223042 [No Abstract] [Full Text] [Related]
5. Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain. Kang SG; Lee HJ; Park YM; Choi JE; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):160-3. PubMed ID: 17804136 [TBL] [Abstract][Full Text] [Related]
6. Association of the MTHFR gene with antipsychotic-induced metabolic abnormalities in patients with schizophrenia. Kuzman MR; Müller DJ Pharmacogenomics; 2012 Jun; 13(8):843-6. PubMed ID: 22676185 [No Abstract] [Full Text] [Related]
7. C825T polymorphism in the human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in the Chinese population. Wang YC; Bai YM; Chen JY; Lin CC; Lai IC; Liou YJ Pharmacogenet Genomics; 2005 Oct; 15(10):743-8. PubMed ID: 16141801 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics and schizophrenia. Foster A; Miller DD; Buckley PF Psychiatr Clin North Am; 2007 Sep; 30(3):417-35. PubMed ID: 17720030 [TBL] [Abstract][Full Text] [Related]
9. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. Saddichha S; Ameen S; Akhtar S J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337 [TBL] [Abstract][Full Text] [Related]
11. Association study of energy homeostasis genes and antipsychotic-induced weight gain in patients with schizophrenia. Jassim G; Fernø J; Theisen FM; Haberhausen M; Christoforou A; Håvik B; Gebhardt S; Remschmidt H; Mehler-Wex C; Hebebrand J; Lehellard S; Steen VM Pharmacopsychiatry; 2011 Jan; 44(1):15-20. PubMed ID: 20821366 [TBL] [Abstract][Full Text] [Related]
12. Comments on "Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine". Reis de Sá A; Elkis H Braz J Psychiatry; 2007 Mar; 29(1):90; author reply 91. PubMed ID: 17435940 [No Abstract] [Full Text] [Related]
14. Long-term treatment with atypical antipsychotics and risk of weight gain. Stip E; Anselmo K; Wolfe M; Lessard C; Landry P Drug Saf; 2006; 29(6):550-2; author reply 552. PubMed ID: 16752937 [No Abstract] [Full Text] [Related]
15. No evidence for an association between G protein beta3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia. Lee HJ; Kang SG; Paik JW; Lee MS; Cho BH; Park YM; Kim W; Choi JE; Jung IK; Kim L; Lee MS Hum Psychopharmacol; 2007 Dec; 22(8):501-4. PubMed ID: 17726725 [TBL] [Abstract][Full Text] [Related]
16. Genetics of antipsychotic treatment emergent weight gain in schizophrenia. Müller DJ; Kennedy JL Pharmacogenomics; 2006 Sep; 7(6):863-87. PubMed ID: 16981847 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis. Sicard MN; Zai CC; Tiwari AK; Souza RP; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ Pharmacogenomics; 2010 Nov; 11(11):1561-71. PubMed ID: 21121776 [TBL] [Abstract][Full Text] [Related]
18. Olanzapine and weight gain. Isaac MB; Isaac MT Am J Psychiatry; 2005 Sep; 162(9):1764-5; author reply 1765. PubMed ID: 16135655 [No Abstract] [Full Text] [Related]
19. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885 [TBL] [Abstract][Full Text] [Related]
20. Is olanzapine a brain-sparing medication? Joober R; Schmitz N; Malla A; Sengupta S; Karma S Arch Gen Psychiatry; 2006 Nov; 63(11):1292. PubMed ID: 17088510 [No Abstract] [Full Text] [Related] [Next] [New Search]